University of Jena
uni-jena.deTotal trials
89
Active
3
Phase 3
6
Total enrollment
214,411
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Dasatinib | — | — | — | — | 2 | ||
| Imatinib | — | — | — | — | — | 1 | |
| Nilotinib 300 mg | — | — | — | — | — | 1 | |
| Asciminib | — | — | — | — | — | 1 | |
| neoadjuvant and adjuvant chemotherapy | — | — | — | — | — | 1 |
Next readouts
- 2026-12-31
- 2027-12
Top conditions
- Cystic Fibrosis6
- Hypercholesterolemia5
- Healthy4
- Healthy Subjects2
- Rhinosinusitis2
- Sinusitis2
- Liver Disease (Alcoholic or Not)2
- Rheumatoid Arthritis2
Frequently asked questions about University of Jena
- How many clinical trials does University of Jena have on ClinicalTrials.gov?
- University of Jena is listed as the lead sponsor on 89 clinical trials in ClinicalTrials.gov, 3 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Jena's trials are in Phase 3?
- 6 of University of Jena's trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does University of Jena focus on?
- University of Jena's most-studied conditions on ClinicalTrials.gov are Cystic Fibrosis, Hypercholesterolemia, Healthy, Healthy Subjects, Rhinosinusitis.
- When are University of Jena's next clinical trial readouts?
- University of Jena has 2 upcoming primary-completion readouts tracked here; the soonest is “Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.”, expected around 2026-12-31.